Makabenta, Jessa Marie V. http://orcid.org/0000-0002-2062-7914
Nabawy, Ahmed http://orcid.org/0000-0001-6505-4606
Li, Cheng-Hsuan http://orcid.org/0000-0002-3334-5756
Schmidt-Malan, Suzannah
Patel, Robin
Rotello, Vincent M. http://orcid.org/0000-0002-5184-5439
Article History
Accepted: 10 July 2020
First Online: 19 August 2020
Competing interests
: R.P. reports grants from CD Diagnostics, Merck, Hutchison Biofilm Medical Solutions, Accelerate Diagnostics, ContraFect, TenNor Therapeutics Limited and Shionogi. R.P. is a consultant to Curetis, Specific Technologies, Next Gen Diagnostics, PathoQuest, Selux Diagnostics, 1928 Diagnostics and Qvella; monies are paid to Mayo Clinic. In addition, R.P. has a patent on <i>Bordetella pertussis/parapertussis</i> PCR issued, a patent on a device/method for sonication with royalties paid by Samsung to Mayo Clinic and a patent on an antibiofilm substance issued. R.P. receives travel reimbursement from the American Society for Microbiology (ASM) and the Infectious Disease Society of America (IDSA), an editor’s stipend from IDSA and honoraria from NBME, Up-to-Date and the Infectious Diseases Board Review Course. All other authors declare no competing interests.